Cargando…
Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway
Epithelial ovarian cancer (EOC) is the most lethal of the gynecological malignancies. Exploring the molecular mechanisms and major factors of invasion and metastasis could have great significance for the treatment and prognosis of EOC. Studies have demonstrated that microRNA 106b (miR-106b) may be a...
Autores principales: | Chen, Shuo, Chen, Xi, Xiu, Yin-Ling, Sun, Kai-Xuan, Zhao, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416747/ https://www.ncbi.nlm.nih.gov/pubmed/25933027 http://dx.doi.org/10.1371/journal.pone.0125714 |
Ejemplares similares
-
RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression
por: Chen, Xi, et al.
Publicado: (2015) -
Role of the lncRNA ABHD11-AS(1) in the tumorigenesis and progression of epithelial ovarian cancer through targeted regulation of RhoC
por: Wu, Dan-Dan, et al.
Publicado: (2017) -
The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cells
por: Gou, Wen-feng, et al.
Publicado: (2014) -
MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC)
por: Liu, Bo-Liang, et al.
Publicado: (2015) -
The Involvement of RhoA and Wnt-5a in the Tumorigenesis and Progression of Ovarian Epithelial Carcinoma
por: Chen, Shuo, et al.
Publicado: (2013)